/PRNewswire/ The result of clinical study for EUA (emergency use authorization) on COVID-19 with Xaftyâ„¢ (CP-COV03) was presented at the Emerging Science .
– Post-hoc analysis results with VOWST highlight the importance of gut microbiome diversity as a critical component of a treatment regimen to reduce the risk of recurrent C. difficile infection. | June 17, 2023
The Penicillin of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug vietreader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietreader.com Daily Mail and Mail on Sunday newspapers.